Systemic gaps in pediatric neurodiversity care drive interest in cannabis research
Original framing: “Can medicinal cannabis help kids’ autism, ADHD or Tourette’s? Here’s what we know so far” — The Conversation - Global
Indigenous communities have used cannabis for centuries as part of a holistic health framework that integrates mind, body, and spirit. These traditions emphasize context-specific use and community stewardship, offering a contrast to the pharmaceutical model that dominates Western medicine.
The current discourse on medicinal cannabis for pediatric neurodevelopmental conditions reflects a systemic failure to provide adequate support for neurodivergent children.
By centering the voices of marginalized communities and integrating cross-cultural and Indigenous knowledge, we can move beyond the pharmaceutical paradigm toward more holistic, inclusive care models. Historical patterns of cannabis suppression and biomedical reductionism must be addressed through regulatory reform and investment in community-based health infrastructure. Future research must be guided by ethical principles that prioritize safety, equity, and the lived experiences of those most affected.